I forgot the name of the drug, but there's a contender for OSA, its not as effective and it is a methamphetamine derivative, completely forgot it and have tried googling a bit to no avail.
However, this company has a connection to ResMed, from memory it's a board member from ResMed on their board. This just confirms our beliefs that ResMed are aware of the disruption that new drugs could cause to their whole business and as such are hedging their bets, it's really good news for all of us to hear that there are talks with them regarding 42x.
Excellent news r.e. Bob, thanks so much for the update on the Melbourne meeting
IHL Price at posting:
9.4¢ Sentiment: Hold Disclosure: Held
